Universe Pharmaceuticals INC (UPC)
4.691
+0.026 (0.55%)
Inactive · Last trade price on Sep 23, 2026
UPC Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 24 | 2 | 6 | 3 | 12 | 54 | |
Market Cap Growth | 831.72% | -58.99% | 66.62% | -71.82% | -77.13% | - |
Enterprise Value | 4 | -37 | 1 | -19 | -12 | 20 |
Last Close Price | 4.69 | 4.20 | 146.40 | 570.00 | 2034.00 | 8891.99 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | - | - | - | 4.75 |
PS Ratio | 1.33 | 0.13 | 0.25 | 0.11 | 0.31 | 1.12 |
PB Ratio | 0.05 | 0.04 | 0.13 | 0.12 | 0.27 | 0.91 |
P/TBV Ratio | 0.43 | 0.04 | 0.13 | 0.12 | 0.27 | 0.91 |
P/FCF Ratio | - | - | - | 3.23 | - | - |
P/OCF Ratio | - | - | - | 3.10 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 0.23 | - | 0.04 | - | - | 0.43 |
EV/EBITDA Ratio | - | - | - | - | - | 1.46 |
EV/EBIT Ratio | - | - | - | - | - | 1.51 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 0.17 | 0.17 | 0.18 | 0.20 | 0.09 | 0.07 |
Debt / EBITDA Ratio | - | - | - | - | - | 0.31 |
Debt / FCF Ratio | - | - | - | 5.11 | - | - |
Net Debt / Equity Ratio | -0.35 | -0.43 | -0.47 | 0.01 | -0.32 | -0.30 |
Net Debt / EBITDA Ratio | 12.11 | 10.15 | 2.85 | -0.06 | 2.30 | -1.24 |
Net Debt / FCF Ratio | 1.57 | 4.58 | 2.21 | 0.18 | 10.70 | 1.12 |
Asset Turnover | 0.23 | 0.26 | 0.42 | 0.64 | 0.62 | 0.97 |
Inventory Turnover | 2.99 | 3.12 | 5.60 | 7.93 | 7.82 | 10.37 |
Quick Ratio | 3.25 | 3.55 | 2.33 | 1.33 | 2.60 | 3.36 |
Current Ratio | 4.05 | 4.07 | 2.54 | 1.84 | 3.17 | 4.50 |
Return on Equity (ROE) | -3.50% | -7.23% | -23.76% | -17.69% | -15.01% | 28.39% |
Return on Assets (ROA) | -1.72% | -2.66% | -9.14% | -4.90% | -6.77% | 17.17% |
Return on Invested Capital (ROIC) | -5.78% | -10.45% | -30.75% | -13.29% | -19.24% | 41.01% |
Return on Capital Employed (ROCE) | -3.60% | -5.20% | -16.80% | -14.20% | -15.10% | 23.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Earnings Yield | -8.24% | -155.20% | -151.27% | -190.05% | -64.37% | 21.07% |
FCF Yield | -52.59% | -224.81% | -169.04% | 30.98% | -11.36% | -29.02% |
Buyback Yield / Dilution | -205.01% | -3174.93% | - | - | - | - |